| Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline S Lutz, L Berk, E Chang, E Chow, C Hahn, P Hoskin, D Howell, A Konski, ... International Journal of Radiation Oncology* Biology* Physics 79 (4), 965-976, 2011 | 1021 | 2011 |
| Randomized trial of short-versus long-course radiotherapy for palliation of painful bone metastases WF Hartsell, CB Scott, DW Bruner, CW Scarantino, RA Ivker, M Roach III, ... Journal of the National Cancer Institute 97 (11), 798-804, 2005 | 950 | 2005 |
| Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial PD Brown, S Pugh, NN Laack, JS Wefel, D Khuntia, C Meyers, A Choucair, ... Neuro-oncology 15 (10), 1429-1437, 2013 | 921 | 2013 |
| Development of the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) E Basch, BB Reeve, SA Mitchell, SB Clauser, LM Minasian, AC Dueck, ... Journal of the National Cancer Institute 106 (9), dju244, 2014 | 883 | 2014 |
| Radiotherapy and short-term androgen deprivation for localized prostate cancer CU Jones, D Hunt, DG McGowan, MB Amin, MP Chetner, DW Bruner, ... New England Journal of Medicine 365 (2), 107-118, 2011 | 803 | 2011 |
| Validity and reliability of the US National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) AC Dueck, TR Mendoza, SA Mitchell, BB Reeve, KM Castro, LJ Rogak, ... JAMA oncology 1 (8), 1051-1059, 2015 | 713 | 2015 |
| Hippocampal avoidance during whole-brain radiotherapy plus memantine for patients with brain metastases: phase III trial NRG oncology CC001 PD Brown, V Gondi, S Pugh, WA Tome, JS Wefel, TS Armstrong, JA Bovi, ... Journal of Clinical Oncology 38 (10), 1019-1029, 2020 | 638 | 2020 |
| Randomized phase III noninferiority study comparing two radiotherapy fractionation schedules in patients with low-risk prostate cancer WR Lee, JJ Dignam, MB Amin, DW Bruner, D Low, GP Swanson, ... Journal of Clinical Oncology 34 (20), 2325, 2016 | 609 | 2016 |
| Sexual satisfaction and the importance of sexual health to quality of life throughout the life course of US adults KE Flynn, L Lin, DW Bruner, JM Cyranowski, EA Hahn, DD Jeffery, ... The journal of sexual medicine 13 (11), 1642-1650, 2016 | 464 | 2016 |
| Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology … JM Michalski, Y Yan, D Watkins-Bruner, WR Bosch, K Winter, JM Galvin, ... International Journal of Radiation Oncology* Biology* Physics 87 (5), 932-938, 2013 | 327 | 2013 |
| A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment CM Reilly, DW Bruner, SA Mitchell, LM Minasian, E Basch, AC Dueck, ... Supportive Care in Cancer 21, 1525-1550, 2013 | 318 | 2013 |
| Effect of standard vs dose-escalated radiation therapy for patients with intermediate-risk prostate cancer: the NRG oncology RTOG 0126 randomized clinical trial JM Michalski, J Moughan, J Purdy, W Bosch, DW Bruner, JP Bahary, ... JAMA oncology 4 (6), e180039-e180039, 2018 | 317 | 2018 |
| Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials BB Reeve, SA Mitchell, AC Dueck, E Basch, D Cella, CM Reilly, ... JNCI: Journal of the National Cancer Institute 106 (7), dju129, 2014 | 305 | 2014 |
| Patient-reported toxicity during pelvic intensity-modulated radiation therapy: NRG Oncology–RTOG 1203 AH Klopp, AR Yeung, S Deshmukh, KM Gil, L Wenzel, SN Westin, ... Journal of clinical oncology 36 (24), 2538, 2018 | 287 | 2018 |
| Relative risk of prostate cancer for men with affected relatives: systematic review and meta‐analysis D Watkins Bruner, D Moore, A Parlanti, J Dorgan, P Engstrom International journal of cancer 107 (5), 797-803, 2003 | 280 | 2003 |
| TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group A Trotti, TF Pajak, CK Gwede, R Paulus, J Cooper, A Forastiere, JA Ridge, ... The lancet oncology 8 (7), 613-624, 2007 | 246 | 2007 |
| Vaginal stenosis and sexual function following intracavitary radiation for the treatment of cervical and endometrial carcinoma DW Bruner, R Lanciano, M Keegan, B Corn, E Martin, GE Hanks International Journal of Radiation Oncology* Biology* Physics 27 (4), 825-830, 1993 | 237 | 1993 |
| Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non–small-cell lung cancer: an analysis of RTOG 9801 B Movsas, J Moughan, L Sarna, C Langer, M Werner-Wasik, N Nicolaou, ... Journal of clinical oncology 27 (34), 5816, 2009 | 225 | 2009 |
| Patterns and risk factors associated with aromatase inhibitor‐related arthralgia among breast cancer survivors JJ Mao, C Stricker, D Bruner, S Xie, MA Bowman, JT Farrar, BT Greene, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2009 | 211 | 2009 |
| Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of Radiation Therapy Oncology Group … V Gondi, R Paulus, DW Bruner, CA Meyers, EM Gore, A Wolfson, ... International Journal of Radiation Oncology* Biology* Physics 86 (4), 656-664, 2013 | 191 | 2013 |
